Aksoy S - Search Results

1

Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.

Demirci NS, Aksoy S, Özdemir NY, Erdem GU, Ozcelik M, Tanrikulu E, Eren T, Bozkaya Y, Sahin S, Başol F, Aslan SA, Zengin N, Güllü İ. Demirci NS, et al. Among authors: aksoy s. Curr Med Res Opin. 2017 Mar;33(3):401-407. doi: 10.1080/03007995.2016.1257984. Epub 2016 Dec 8. Curr Med Res Opin. 2017. PMID: 27817239

2

Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties.

Aksoy S, Abali H, Dinçer M, Kilickap S, Güllü I, Tekuzman G. Aksoy S, et al. Med Hypotheses. 2004;62(6):942-4. doi: 10.1016/j.mehy.2004.02.001. Med Hypotheses. 2004. PMID: 15142653

3

Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.

Altundag K, Aksoy S, Gullu I, Altundag O, Ozyar E, Yalcin S, Cengiz M, Akyol F. Altundag K, et al. Among authors: aksoy s. Med Oncol. 2004;21(3):211-5. doi: 10.1385/MO:21:3:211. Med Oncol. 2004. PMID: 15456947

4

Peripheral T-cell lymphoma and Job's syndrome: a rare association.

Onal IK, Kurt M, Altundag K, Aksoy S, Dincer M, Gullu I. Onal IK, et al. Among authors: aksoy s. Med Oncol. 2006;23(1):141-4. doi: 10.1385/MO:23:1:141. Med Oncol. 2006. PMID: 16645241

5

Potential chemotherapy options in the triple negative subtype of breast cancer.

Altundag K, Harputluoglu H, Aksoy S, Gullu IH. Altundag K, et al. Among authors: aksoy s. J Clin Oncol. 2007 Apr 1;25(10):1294-5; author reply 1295-6. doi: 10.1200/JCO.2006.10.0883. J Clin Oncol. 2007. PMID: 17401026 No abstract available.

6

Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.

Dincer M, Altundag K, Harputluoglu H, Aksoy S, Cengiz M, Gullu I. Dincer M, et al. Among authors: aksoy s. Med Oncol. 2008;25(3):356-9. doi: 10.1007/s12032-008-9045-3. Epub 2008 Jan 15. Med Oncol. 2008. PMID: 18196480

7

Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.

Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K. Harputluoglu H, et al. Among authors: aksoy s. J Natl Med Assoc. 2008 May;100(5):521-6. doi: 10.1016/s0027-9684(15)31298-0. J Natl Med Assoc. 2008. PMID: 18507204

8

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer.

Bulut N, Aksoy S, Dizdar O, Dede DS, Arslan C, Dogan E, Gullu I, Ozisik Y, Altundag K. Bulut N, et al. Among authors: aksoy s. Med Oncol. 2011 Dec;28 Suppl 1:S75-9. doi: 10.1007/s12032-010-9715-9. Epub 2010 Oct 21. Med Oncol. 2011. PMID: 20963641

9

Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.

Uncu D, Ozdemir NY, Aksoy S, Abali H, Oksuzoglu BC, Budakoglu B, Yildiz R, Aslan N, Zengin N. Uncu D, et al. Among authors: aksoy s. Asian Pac J Cancer Prev. 2010;11(6):1493-7. Asian Pac J Cancer Prev. 2010. PMID: 21338186 Free article.

10

Successful treatment of chronic hiccup with baclofen in cancer patients.

Seker MM, Aksoy S, Ozdemir NY, Uncu D, Civelek B, Akıncı MB, Zengin N. Seker MM, et al. Among authors: aksoy s. Med Oncol. 2012 Jun;29(2):1369-70. doi: 10.1007/s12032-011-9910-3. Epub 2011 Mar 26. Med Oncol. 2012. PMID: 21442315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters